ES2135424T3 - Composicion oral a base de ibuprofeno. - Google Patents

Composicion oral a base de ibuprofeno.

Info

Publication number
ES2135424T3
ES2135424T3 ES93103467T ES93103467T ES2135424T3 ES 2135424 T3 ES2135424 T3 ES 2135424T3 ES 93103467 T ES93103467 T ES 93103467T ES 93103467 T ES93103467 T ES 93103467T ES 2135424 T3 ES2135424 T3 ES 2135424T3
Authority
ES
Spain
Prior art keywords
ibuprofen
approximately
oral composition
composition based
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93103467T
Other languages
English (en)
Inventor
Galli Angeli Depalmo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Angelini Acraf SpA
Original Assignee
Aziende Chimiche Riunite Angelini Francesco ACRAF SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aziende Chimiche Riunite Angelini Francesco ACRAF SpA filed Critical Aziende Chimiche Riunite Angelini Francesco ACRAF SpA
Application granted granted Critical
Publication of ES2135424T3 publication Critical patent/ES2135424T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Abstract

UNA COMPOSICION FARMACEUTICA PARA LA ADMINISTRACION ORAL DE IBUPROFENO COMO PRINCIPIO ACTIVO QUE CONTIENE UNA SOLUCION ACUOSA DE (A) PIRIDOXINA O DE UNA SAL FARMACEUTICAMENTE ACEPTABLE DE LA MISMA, EN UNA RELACION NO SUPERIOR A 1/8 APROXIMADAMENTE Y 1/2 APROXIMADAMENTE, EN PESO, EN RELACION AL PESO DE IBUPROFENO COMO IBUPROFENO EN SU ESTADO ACIDICO Y (B) UNA SAL DE IBUPROFENO TERAPEUTICAMENTE ACEPTABLE, JUNTO CON EXCIPIENTES INERTES FARMACEUTICAMENTE APTOS.
ES93103467T 1992-03-12 1993-03-04 Composicion oral a base de ibuprofeno. Expired - Lifetime ES2135424T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM920173A IT1262953B (it) 1992-03-12 1992-03-12 Composizione a base di ibuprofen per uso orale.

Publications (1)

Publication Number Publication Date
ES2135424T3 true ES2135424T3 (es) 1999-11-01

Family

ID=11400805

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93103467T Expired - Lifetime ES2135424T3 (es) 1992-03-12 1993-03-04 Composicion oral a base de ibuprofeno.

Country Status (8)

Country Link
EP (1) EP0560207B1 (es)
AT (1) ATE181828T1 (es)
BG (1) BG61892B2 (es)
DE (1) DE69325531T2 (es)
DK (1) DK0560207T3 (es)
ES (1) ES2135424T3 (es)
GR (1) GR3031360T3 (es)
IT (1) IT1262953B (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4579846A (en) * 1984-10-11 1986-04-01 Pfizer Inc. Antiinflammatory compositions and methods

Also Published As

Publication number Publication date
BG61892B2 (bg) 1998-08-31
ITRM920173A1 (it) 1993-09-12
ATE181828T1 (de) 1999-07-15
EP0560207B1 (en) 1999-07-07
DK0560207T3 (da) 2000-02-07
IT1262953B (it) 1996-07-23
EP0560207A1 (en) 1993-09-15
GR3031360T3 (en) 2000-01-31
DE69325531D1 (de) 1999-08-12
DE69325531T2 (de) 2000-03-23
ITRM920173A0 (it) 1992-03-12

Similar Documents

Publication Publication Date Title
FI970164A0 (fi) Inhalaatioformula
ES2188782T3 (es) Formulaciones farmaceuticas que contienen darifenacina.
DE69534538D1 (de) Verzögerte Freisetzung von Peptiden aus pharmazeutischen Zusammensetzungen
MY105121A (en) Pharmaceutical composition for systemic transdermal administration.
GR3004509T3 (es)
MY118371A (en) Tetrahydrolipstatin containing compositions
TW355683B (en) Composition containing micronized nebivolol
ES2160577T3 (es) Nuevos esteres de aminoalcoholes biciclicos y triciclicos, su preparacion y su utilizacion en medicamentos.
DE69628163D1 (de) Nor-pregnane zur induzierung hypothalamischer effekte
PH24377A (en) Formulations suitable for the stabilisation of alpha-interferon
IT1263840B (it) Formulazioni orali di ubidecarenone in forma di capsule
IT1252692B (it) Composizione farmaceutica per uso oftalmico contenente un antiinfiammatorio non steroideo ed un decongestionante come principi attivi
DE69322251T2 (de) Medizinische zusammensetzung
FR2674754B1 (fr) Composition medicamenteuse micronisee.
PH27446A (en) Compound with gastric acid inhibitory effect
ZA881053B (en) Prostaglandin e1 derivatives as pharmacologically active agents,and pharmaceutical compositions containing these compounds,especially for transcutaneous administration
IT1256623B (it) Antagonisti delle tachichinine, procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche
ES2135424T3 (es) Composicion oral a base de ibuprofeno.
CA2120001A1 (en) Flavopereirine-based pharmaceutical composition and use thereof for treating hiv
DK0524696T3 (da) Orale præparater indeholdende dapiprazol
ES2064104T3 (es) Procedimiento de preparacion de composiciones farmaceuticas del tipo de liberacion prolongada destinadas a la administracion por via oral.
ES2103422T3 (es) Uso de bilobalida y sus derivados para tratar una infeccion en un individuo y composiciones farmaceuticas destinadas a dicho uso.
AR010343A1 (es) Uso de 17 beta-dihidroequilenina o una sal farmaceuticamente aceptable del ester de 17 beta-dihidroequilenina-3-sulfato para la manufactura de unmedicamento como antioxidante y composicion farmaceutica.
ITBO930460A1 (it) Procedimento per preparare forme farmaceutiche a rilascio controllato del principio attivo e le forme farmaceutiche cosi' ottenute.
CA2066945A1 (en) Oral, cutaneous and intravaginal pharmaceutical compositions in the form of foam

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 560207

Country of ref document: ES